In vitro activity of new quinolones against clinical strains of Staphylococcus aureus of the wild type and with mutations characterized by gyrA, gyrB and grlA
Actividad in vitro de nuevas quinolonasfrente a cepas clínicas de Staphylococcus aureussilvestres y con mutaciones caracterizadasen gyrA, gyrB y grlA